XW043W5Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5

XW043W5 is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with caplacizumab (qualifier: new technology group 5). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW013W5 (subcutaneous tissue) and XW033W5 (peripheral vein).

With a different device, use XW043E5 (remdesivir anti-infective), XW043F5 (other new technology therapeutic substance), XW043G5 (vancomycin hydrochloride and tobramycin sulfate anti-infective, temporary irrigation spacer system), XW043H5 (paclitaxel-coated balloon technology, one balloon), XW043Q5 (iloprost) and XW043S5 (iobenguane I-131 antineoplastic).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2020, effective October 1, 2019.